CORE
🇺🇦
make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT ® nanoparticle formulation against non-small-cell lung cancer brain metastases
Authors
Carey K Anders
Charles Bowerman
+9 more
Kevin Chu
Allison Deal
Joseph Desimone
Olga Karginova
J Christopher Luft
Maria Sambade
Allison Schorzman
Amanda Van Swearingen
William Zamboni
Publication date
1 January 2016
Publisher
Doi
Cite
View
on
PubMed
Abstract
Particle Replication in Nonwetting Templates (PRINT®) PLGA nanoparticles of docetaxel and acid-labile C2-dimethyl-Si-Docetaxel were evaluated with small molecule docetaxel as treatments for non-small-cell lung cancer brain metastases
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Carolina Digital Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
cdr.lib.unc.edu:5m60qx99w
Last time updated on 23/04/2020